surmount-1 tirzepatide trial obesity without diabetes In the (published in NEJM in July 2022) in participants with #obesity, 5 mg, 10 mg, or 15 mg of once weekly provided substantial and sustained reductions in body weight. Tirzepatide for Obesity: Highlights from
Description
doi: 10.2337/dc141984 30 BarreJLStillEU

Lauffenburger JC, Lewey J, Jan S, Lee J, Ghazinouri R, Choudhry NK

Call 800-277-4041 for a Free Consultation What to expect during your consultation:

At En Vogue IV Therapy & Wellness, we prioritize safety when using Tirzepatide for weight loss

This flexibility allows you to adjust your schedule to better fit your routine while maintaining therapeutic consistency
